Publication | Closed Access

Pharmacokinetics of decitabine administered as a 3-h infusion to patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS)

Hematological MalignancyMyelodysplastic SyndromeMedicineAcute Myeloid LeukemiaHematology3-H InfusionPharmacotherapyPharmacologyPharmacokinetics